High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis

@article{Renneville2006HighOO,
  title={High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis},
  author={Aline Renneville and Bruno Quesnel and Agn{\`e}s Charpentier and Louis Terriou and Antoine Crinquette and J-L La{\"i} and C Cossement and Pauline Lionne-Huyghe and Christian Rose and Francis Bauters and Claude Joseph Preudhomme},
  journal={Leukemia},
  year={2006},
  volume={20},
  pages={2067-2070}
}
3101–3108. 8 Takubo T, Kanashima H, Terada Y, Aoyama Y, Nakamae H, Yamamura R et al. Clinical significance of serum E-cadherin levels in patients with haematological malignancies. Haematologia (Budapest) 2002; 31: 319–325. 9 Nasu H, Hibi N, Ohyashiki JH, Hara A, Kubono K, Tsukada Y et al. Soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromes. Int J Oncol 1998; 13: 525–530. 10 Melki JR, Vincent PC, Brown RD, Clark SJ. Hypermethylation of E-cadherin in… CONTINUE READING